Debt-to-equity of Vir Biotechnology, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Vir Biotechnology, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • Vir Biotechnology, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 25%, a 35% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Vir Biotechnology, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 25% +7% +35% 30 Sep 2025
Q2 2025 23% 30 Jun 2025
Q1 2025 21% 31 Mar 2025
Q4 2024 18% 31 Dec 2024
Q3 2024 18% 30 Sep 2024
Q1 2023 32% -9% -21% 31 Mar 2023
Q4 2022 35% -10% -23% 31 Dec 2022
Q3 2022 35% -10% -23% 30 Sep 2022
Q2 2022 38% -1% -1.3% 30 Jun 2022
Q1 2022 41% +7% +21% 31 Mar 2022
Q4 2021 45% +23% +107% 31 Dec 2021
Q3 2021 45% +26% +131% 30 Sep 2021
Q2 2021 39% +6% +18% 30 Jun 2021
Q1 2021 34% 31 Mar 2021
Q4 2020 22% 31 Dec 2020
Q3 2020 19% 30 Sep 2020
Q2 2020 33% 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.